These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 36046692)
41. Isoproterenol-induced hypertrophy of neonatal cardiac myocytes and H9c2 cell is dependent on TRPC3-regulated Ca Han JW; Kang C; Kim Y; Lee MG; Kim JY Cell Calcium; 2020 Dec; 92():102305. PubMed ID: 33069962 [TBL] [Abstract][Full Text] [Related]
42. Ubiquitin-protein ligase E3a (UBE3A) as a new biomarker of cardiac hypertrophy in cell models. Cheng KC; Li Y; Chang WT; Chen ZC; Cheng JT; Tsai CC J Food Drug Anal; 2019 Jan; 27(1):355-364. PubMed ID: 30648591 [TBL] [Abstract][Full Text] [Related]
43. Astragalus polysaccharide inhibits isoprenaline-induced cardiac hypertrophy via suppressing Ca²⁺-mediated calcineurin/NFATc3 and CaMKII signaling cascades. Dai H; Jia G; Liu X; Liu Z; Wang H Environ Toxicol Pharmacol; 2014 Jul; 38(1):263-71. PubMed ID: 24975447 [TBL] [Abstract][Full Text] [Related]
44. Hyperhomocysteinemia-induced Nrf2/HO-1 pathway suppression aggravates cardiac remodeling of hypertensive rats. Cao P; Zhang W; Kong X; Gao N; Zhao X; Xu R Biochem Biophys Res Commun; 2021 Apr; 547():125-130. PubMed ID: 33610040 [TBL] [Abstract][Full Text] [Related]
45. Folic acid enhances the cardiovascular protective effect of amlodipine in renal hypertensive rats with elevated homocysteine. Li L; Tong X; Ma Z; Lv L; Liu H; Chen GL Clin Exp Hypertens; 2023 Dec; 45(1):2205058. PubMed ID: 37154141 [TBL] [Abstract][Full Text] [Related]
46. Cardiac anti-remodelling effect of aerobic training is associated with a reduction in the calcineurin/NFAT signalling pathway in heart failure mice. Oliveira RS; Ferreira JC; Gomes ER; Paixão NA; Rolim NP; Medeiros A; Guatimosim S; Brum PC J Physiol; 2009 Aug; 587(Pt 15):3899-910. PubMed ID: 19505981 [TBL] [Abstract][Full Text] [Related]
47. FKBP12.6 protects heart from AngII-induced hypertrophy through inhibiting Ca Xiao YF; Zeng ZX; Guan XH; Wang LF; Wang CJ; Shi H; Shou W; Deng KY; Xin HB J Cell Mol Med; 2018 Jul; 22(7):3638-3651. PubMed ID: 29682889 [TBL] [Abstract][Full Text] [Related]
48. Cytosolic CARP promotes angiotensin II- or pressure overload-induced cardiomyocyte hypertrophy through calcineurin accumulation. Chen C; Shen L; Cao S; Li X; Xuan W; Zhang J; Huang X; Bin J; Xu D; Li G; Kitakaze M; Liao Y PLoS One; 2014; 9(8):e104040. PubMed ID: 25089522 [TBL] [Abstract][Full Text] [Related]
50. Targeted disruption of Hspa4 gene leads to cardiac hypertrophy and fibrosis. Mohamed BA; Barakat AZ; Zimmermann WH; Bittner RE; Mühlfeld C; Hünlich M; Engel W; Maier LS; Adham IM J Mol Cell Cardiol; 2012 Oct; 53(4):459-68. PubMed ID: 22884543 [TBL] [Abstract][Full Text] [Related]
51. Effect of Homocysteine on the Differentiation of CD4 Gao X; Li J; Chen M Dig Dis Sci; 2018 Dec; 63(12):3339-3347. PubMed ID: 29974377 [TBL] [Abstract][Full Text] [Related]
52. Dexamethasone promotes hypertrophy of H9C2 cardiomyocytes through calcineurin B pathway, independent of NFAT activation. Sangeetha KN; Lakshmi BS; Niranjali Devaraj S Mol Cell Biochem; 2016 Jan; 411(1-2):241-52. PubMed ID: 26511233 [TBL] [Abstract][Full Text] [Related]
53. Telmisartan suppresses cardiac hypertrophy by inhibiting cardiomyocyte apoptosis via the NFAT/ANP/BNP signaling pathway. Li X; Lan Y; Wang Y; Nie M; Lu Y; Zhao E Mol Med Rep; 2017 May; 15(5):2574-2582. PubMed ID: 28447738 [TBL] [Abstract][Full Text] [Related]
54. Cardiomyocyte calcineurin is required for the onset and progression of cardiac hypertrophy and fibrosis in adult mice. Martínez-Martínez S; Lozano-Vidal N; López-Maderuelo MD; Jiménez-Borreguero LJ; Armesilla ÁL; Redondo JM FEBS J; 2019 Jan; 286(1):46-65. PubMed ID: 30548183 [TBL] [Abstract][Full Text] [Related]
55. Caveolin-3 Overexpression Attenuates Cardiac Hypertrophy via Inhibition of T-type Ca2+ Current Modulated by Protein Kinase Cα in Cardiomyocytes. Markandeya YS; Phelan LJ; Woon MT; Keefe AM; Reynolds CR; August BK; Hacker TA; Roth DM; Patel HH; Balijepalli RC J Biol Chem; 2015 Sep; 290(36):22085-100. PubMed ID: 26170457 [TBL] [Abstract][Full Text] [Related]
56. O-GlcNAc signaling is essential for NFAT-mediated transcriptional reprogramming during cardiomyocyte hypertrophy. Facundo HT; Brainard RE; Watson LJ; Ngoh GA; Hamid T; Prabhu SD; Jones SP Am J Physiol Heart Circ Physiol; 2012 May; 302(10):H2122-30. PubMed ID: 22408028 [TBL] [Abstract][Full Text] [Related]